inVentiv Health offers a uniquely wide range of outsourced services for drug development and comprehensive global commercialization. Our clinical and commercial businesses support nearly every aspect of the product lifecycle from first-into-trial to OTC. This breadth of experience allows us to help our clients with some of their most complex challenges and gives us a unique perspective that we share in white papers published monthly by our businesses.
From innovative ways to better manage risk to rethinking communications for more successful reimbursement and planning, here is some of our recent thinking on how we can transform healthcare together from clinical development into commercial reality.
inVentiv Health White Papers
"I was very impressed with the level of industry knowledge...it was a pleasure to work with the team."– Client at Pfizer
"I felt inVentiv was a company that could read between the lines and see the bigger picture of what we’re trying to achieve – from a long-term point of view."– Vice President Sales, Top 10 Pharma
"inVentiv will become even more important to us in the future as we face margin compression, patent cliffs, and the changes in healthcare."– Vice President Sales, Top 10 Pharma
"After an extensive global review of potential clinical research organizations, we selected the broad-scale inVentiv platform as an important differentiator for our program."– President and CEO, Advaxis
To learn more about how inVentiv Health experts can help you, please contact us by clicking here.Contact Us
inVentiv Health has been made aware of an internet scam targeting job seekers who have posted their resumes on job posting websites. Scammers are contacting applicants via email and purporting to represent inVentiv Health. Many of these scammers are using Gmail accounts and Google Hangouts to communicate with applicants. All correspondence with us comes from an internal employee with a valid @inventivhealth.com email address. Anyone who suspects they have been solicited in this scam should contact the FBI at ic3.gov.